Guggenheim Capital LLC lowered its stake in Cavium (NASDAQ:CAVM) by 32.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,220 shares of the semiconductor provider’s stock after selling 7,361 shares during the quarter. Guggenheim Capital LLC’s holdings in Cavium were worth $1,276,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Delpha Capital Management LLC bought a new stake in shares of Cavium in the 4th quarter valued at $114,000. SG Americas Securities LLC bought a new stake in shares of Cavium in the 4th quarter valued at $115,000. Cerebellum GP LLC bought a new stake in shares of Cavium in the 4th quarter valued at $126,000. American International Group Inc. bought a new stake in shares of Cavium in the 4th quarter valued at $131,000. Finally, US Bancorp DE increased its stake in shares of Cavium by 201.3% in the 4th quarter. US Bancorp DE now owns 1,657 shares of the semiconductor provider’s stock valued at $139,000 after acquiring an additional 1,107 shares in the last quarter. Institutional investors own 92.11% of the company’s stock.
Shares of CAVM stock opened at $77.13 on Monday. The firm has a market cap of $5,387.45, a price-to-earnings ratio of 964.13, a price-to-earnings-growth ratio of 1.93 and a beta of 1.34. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.80 and a quick ratio of 2.26. Cavium has a 12 month low of $56.96 and a 12 month high of $92.66.
Cavium (NASDAQ:CAVM) last announced its quarterly earnings results on Wednesday, January 31st. The semiconductor provider reported $0.83 EPS for the quarter, beating the Zacks’ consensus estimate of $0.81 by $0.02. The business had revenue of $260.36 million during the quarter, compared to analyst estimates of $260.05 million. Cavium had a negative net margin of 7.00% and a positive return on equity of 14.07%. Cavium’s quarterly revenue was up 15.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.56 EPS. analysts forecast that Cavium will post 2.13 EPS for the current year.
Several research firms have recently weighed in on CAVM. BidaskClub lowered shares of Cavium from a “hold” rating to a “sell” rating in a research note on Wednesday, April 4th. Zacks Investment Research upgraded shares of Cavium from a “sell” rating to a “hold” rating in a research note on Tuesday, January 23rd. Stifel Nicolaus lifted their price objective on shares of Cavium from $68.00 to $81.00 and gave the company a “hold” rating in a research note on Thursday, February 1st. Raymond James lowered shares of Cavium from an “outperform” rating to a “market perform” rating and set a $80.00 price target for the company. in a research note on Friday, February 2nd. Finally, ValuEngine lowered shares of Cavium from a “hold” rating to a “sell” rating in a research note on Thursday. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $79.33.
In other Cavium news, Director Sanjay Mehrotra sold 12,500 shares of Cavium stock in a transaction on Friday, March 9th. The shares were sold at an average price of $91.20, for a total transaction of $1,140,000.00. Following the transaction, the director now directly owns 85,511 shares of the company’s stock, valued at approximately $7,798,603.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Anil Kumar Jain sold 16,059 shares of Cavium stock in a transaction on Friday, February 16th. The stock was sold at an average price of $87.51, for a total transaction of $1,405,323.09. Following the transaction, the vice president now directly owns 116,274 shares in the company, valued at $10,175,137.74. The disclosure for this sale can be found here. Insiders have sold a total of 353,962 shares of company stock worth $31,361,100 over the last ninety days. Insiders own 4.65% of the company’s stock.
WARNING: This piece was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/23/cavium-cavm-shares-sold-by-guggenheim-capital-llc.html.
Cavium, Inc designs, develops, and markets semiconductor processors for intelligent and secure networks in the United States and internationally. The company offers integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage, and security applications.
Want to see what other hedge funds are holding CAVM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cavium (NASDAQ:CAVM).
Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.